Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating myasthenia gravis

A technology for myasthenia gravis and drugs, which can be used in drug combinations, pharmaceutical formulations, and muscular system diseases to solve the problems of sequelae, long course of disease, and high costs.

Inactive Publication Date: 2005-05-04
姜东海 +1
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment of this disease is mainly based on anticholinesterase drugs, thymectomy, and radiotherapy; but the former can only improve the symptoms; the latter is expensive and causes greater trauma and pain to the patient. There are still sequelae, and it is not suitable for patients with long course of disease, old age and no thymoma
At present, there is no pure Chinese medicine preparation for the treatment of myasthenia gravis at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0072] Embodiments of the invention:

[0073] When the unit of use is gram, it is an effective dosage for one day, and it is taken three times a day, which is a conventional way of taking medicine.

[0074] Weigh raw materials according to the following mass ratio (kg)

[0075] Ginseng: 7 Astragalus: 7 Atractylodes macrocephala: 3.5 Yam: 7

[0076] Jujube: 7 Radix Paeoniae Rubra: 3.5 Angelica: 3.5 Rhizoma Chuanxiong: 3.5

[0077] Tangerine peel: 3.5 Chicken gizzard: 3.5 Grain worms: 2.5 Cimicifuga: 1.5

[0078] Bupleurum: 1.5 Habitat: 3.5 Ligustrum lucidum: 12 Epimedium: 12.5

[0079] Nymph: 3.5 Keel: 3.5 Oyster: 7 Licorice: 3.5

[0080] Tablets are prepared by conventional Chinese patent medicine processing methods.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A medicine for treating myasthenia gravis, which consists of ginseng, astragalus, atractylodes macrocephala, yam, jujube, red peony root, angelica, chuanxiong, nuxony, keel, oyster, licorice, tangerine peel, gallinaceous gold, grain worm, cohosh, Composed of Bupleurum, Shengdi, Ligustrum lucidum, and Epimedium, it follows the principle of "jun, minister, adjuvant, and envoy" in the compatibility of traditional Chinese medicine. It has been clinically used to prove that it has the following advantages: 1. Definite curative effect, can effectively enhance muscle strength, promote appetite. 2. No toxic side effects. 3. It is widely used. In addition to treating myasthenia gravis, it has good curative effect on autoimmune diseases, muscle atrophy, and muscle weakness. It is suitable as a therapeutic drug for myasthenia gravis.

Description

technical field [0001] The invention discloses a medicine for treating myasthenia gravis. Background technique [0002] Myasthenia gravis is a kind of acetylcholine receptor in the post-synaptic membrane at the junction of the motor nerve and muscle binds to its autoantibody, which reduces the function or number of acetylcholine receptors, resulting in the presynaptic membrane from the motor nerve end plate A disorder in which the reversibility of the release of acetylcholine to the postsynaptic membrane is impaired, thereby predisposing striated muscles to fatigue. It can occur at any age, and women are slightly more common than men. The treatment of this disease is mainly based on anticholinesterase drugs, thymectomy, and radiotherapy; but the former can only improve the symptoms; the latter is expensive and causes greater trauma and pain to the patient. There are still sequelae, and it is not suitable for patients with long course of disease, old age and no thymoma. At...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61P21/04
Inventor 姜东海姜京玲
Owner 姜东海
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products